VMValentina Marinković

Valentina Marinković

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valentina Marinković has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ATTITUDES AND PRACTICES TOWARDS COVID-19 AND SEASONAL FLU VACCINES AND VACCINATION IN THE GENERAL POPULATION AND AMONG MEDICAL PROFESSIONALS

    by Katarina Petković, Dušanka Krajnović, Andijana Milošević-Georgijev, Brankica Filipić, Andjela Marinković, Valentina Marinković

    The COVID-19 pandemic has led to the development of several types of vaccines, among which messenger RNA (mRNA)-based vaccines have represented a significant breakthrough. This study aimed to evaluate attitudes towards COVID-19 and seasonal influenza vaccination among the general population and individuals with a medical background. A questionnaire was developed to collect sociodemographic data, personal health information, vaccination status, and information on participants’ attitudes towards and knowledge of vaccines. The profile of the typical participant was an employed woman with tertiary education, living with another person in an urban area and reporting generally good health. The typical participant had received at least two doses of the Sputnik V vaccine. Participants generally expressed favourable attitudes towards regular COVID-19 vaccination. The results showed no apparent differences between participants with and without a medical background regarding vaccine choice, the decision to receive a third dose, or seasonal influenza vaccination. Similarly, no apparent differences were observed in attitudes towards the AstraZeneca vaccine or mandatory COVID-19 vaccination between respondents with and without a medical background.

  • Open Access

    Examining the Level of Knowledge of Teachers About Asthma, Diabetes and Epilepsy in Children: A Systematic Review

    by Aleksandar Petrušić, Miloš N. Milosavljević, Mladen Pavlović, Miroslav M. Sovrlić, Milos Stepovic, Nevena Folic, Valentina Marinković, Andrijana Milošević Georgiev

    Background/Objectives: Asthma, type 1 diabetes mellitus (T1DM), and epilepsy are prevalent chronic diseases among school-aged children, affecting safety, attendance, and academic performance. This systematic review evaluated school teachers’ knowledge, attitudes, and preparedness regarding these conditions and identified gaps that hinder effective management and inclusion. Methods: Following PRISMA guidelines, PubMed, Cochrane Library, Scopus, and Google Scholar were searched between 20 September and 9 October 2025. Forty-nine quantitative cross-sectional studies assessing teachers’ knowledge, attitudes, or preparedness toward asthma, T1DM, or epilepsy were included. The AXIS tool assessed methodological quality, focusing on clarity of objectives, sample justification, ethical transparency, and instrument validation. Results: Teachers’ knowledge was generally moderate and varied by region. Studies on epilepsy (n = 21) highlighted misconceptions and limited understanding of seizure first aid. Diabetes studies (n = 9) indicated moderate awareness but insufficient preparedness for hypoglycemia and insulin management. Asthma studies (n = 19) revealed inconsistent knowledge, particularly regarding symptom recognition and emergency response. AXIS assessment identified recurring limitations, including unjustified sample sizes, limited instrument validation, and poor reporting of non-responders. Conclusions: These findings emphasize the need to enhance school preparedness through targeted, evidence-based teacher training, clear health policies and emergency protocols, awareness and inclusion initiatives, improved collaboration among teachers, parents, and healthcare providers, and strengthened school health infrastructure. Addressing these areas is critical to ensure safe, inclusive, and supportive learning environments for children with chronic illnesses.

  • Open Access

    Prospective Risk Management in the Process of Clinical Studies in the Republic of Serbia

    by Nikola Rabrenović, Ivana Stević, Valentina Marinković

    Background: In Serbia, as well as worldwide, clinical trials are a significant and unavoidable part of the development of new medicines. There is limited research on prospective risk management in clinical trials in Serbia, underscoring the need for systematic approaches, such as the failure mode and effects analysis (FMEA) method. The effectiveness of this complex process largely depends on knowledge and experience in the field of management. Like any other process, clinical trials are subject to various risks for both the company and the patient. Objectives: The purpose of this article is to conduct a prospective, qualitative study on the risk management of clinical trials in the Republic of Serbia, to identify, assess, and reduce risks for both patients and companies, and to offer corrective measures for reducing their frequency and consequences. Materials and Methods: A focus group applied the FMEA method to identify, assess, and mitigate risks. Each risk was assessed based on severity, probability, and detectability, and then a risk priority number (RPN) value was calculated. For the most significant risks, corrective measures were proposed, and the RPN was recalculated. The research was conducted from December 12, 2022 to March 8, 2023. Results: In total, 20 risks were identified with RPN values ranging from 10 to 192, of which five had RPN > 100. The minimum RPN value among the five most significant risks was 105, and the maximum was 192. After the proposed corrective measures, there was a significant reduction in the RPN values across all five risks, ranging from 57.14% to 83.33% when compared to the initial values. Conclusion: The FMEA method has proven to be a useful instrument not only for identifying and predicting potential risks, but also for their control.

  • Open Access

    Supporting children with chronic non-communicable diseases in the school environment: The role of pharmacists in educating school staff

    by A. Petrušić, M. Mihajlović, S. Nikić, A.M. Petrušić, V. Marinković, A. Milošević-Georgiev

    Children with chronic non-communicable diseases require continuous support in the school setting, where teachers play an important role in recognizing health needs, responding to acute events, and maintaining student safety. Pharmacists, as accessible healthcare professionals, may contribute to the education of school staff and strengthen intersectoral collaboration. This study aimed to examine the awareness and experience of school employees in working with children with chronic non-communicable diseases, as well as their views on the role of pharmacists in education and support within the school environment. A cross-sectional study was conducted among 256 educational professionals employed in primary schools in Serbia. Data were collected using an anonymous online questionnaire comprising 22 items covering socio-demographic characteristics, experience with chronically ill children, educational needs, and attitudes toward collaboration with pharmacists. Overall, 59% of respondents reported having a child with a chronic disease in their class, while 36.3% had experienced a situation requiring assistance during an acute exacerbation. Most participants had not received prior training on chronic diseases in children (91.4%), and 64.1% felt only partially confident in dealing with such students. Most respondents considered pharmacists to have a potentially important role in teacher education, particularly in emergency response and proper therapy-related guidance. The findings indicate a substantial need for structured education of school staff and greater involvement of pharmacists in supporting schools in the care of children with chronic non-communicable diseases.

  • Open Access

    Pharmacist counselling for parents of children with chronic non-communicable diseases: Implications for safe and effective therapy use

    by A. Petrušić, T. Boškovski, A. Milošević-Georgiev, S. Nikić, L. Neškov, V. Marinković

    Chronic non-communicable diseases in childhood represent a major clinical and public health challenge due to the need for long-term treatment, continuous monitoring, and active parental involvement in therapy management. As highly accessible healthcare professionals, pharmacists may contribute to improving medication safety, adherence, and family health literacy. This study aimed to examine the attitudes of parents regarding the role of pharmacists in counselling parents of children with chronic non-communicable diseases and to identify key barriers to improving counselling practice. The cross-sectional study was conducted in September 2025. In the research participated 52 pharmacists and pharmaceutical technicians employed in pharmacies in Serbia. Data were collected using an anonymous online questionnaire comprising 21 items on counselling frequency and content, self-perceived knowledge and competence, organizational barriers, and attitudes toward additional professional education pharmacists/pharmaceutical technicians. Most respondents recognized the pharmacist's counselling role as highly important; however, counselling was most often provided only occasionally (57.7%) and within 2-5 minutes (55.8%). Allergies and asthma were the most frequent counselling topics. Although 69.2% of participants reported having basic knowledge of chronic pediatric diseases, most expressed a need for further professional training. The main barriers were lack of time, limited privacy, and insufficient collaboration with physicians. Pharmacists are an important yet underutilized resource in supporting parents of children with chronic non-communicable diseases. Strengthening this role requires additional education, standardized counselling practices, and improved interdisciplinary collaboration.

  • Open Access

    Can the development of emotional intelligence influence stress, burnout, and mental well-being among community pharmacists: Preliminary results of a cross-sectional study

    by D. Senćanski, V. Marinković

    Research on emotional intelligence (EI) in pharmaceutical practice has shown that higher EI is associated with greater motivation, initiative, empathy, communication, leadership, and resilience among pharmacists. Professional development programs for pharmacists in Serbia, however, appear to provide limited support for EI development. To date, the relationship between EI, burnout, and well-being among pharmacists working in Serbian pharmacies has not been explored comprehensively. This cross-sectional study examined the relationships among EI, perceived stress, burnout, and well-being, and the potential mediating role of specific factors. It also investigated the impact of specially designed, accredited educational programs organised by the Pharmaceutical Chamber of Serbia on EI development and related outcomes. Validated questionnaires were used alongside descriptive, correlational, and Hayes' mediation analyses. Invitations to participate were sent electronically to all mandatory Chamber members. A total of 239 pharmacists participated (90.4% female), with a mean age of 40.9±10.3 years and 14.1±9.8 years of work experience. Statistically significant correlations were observed between EI and perceived stress, burnout, and well-being (p<0.01). Participants who completed the educational intervention (n=59) demonstrated lower levels of burnout (p<0.01) than those in the non-intervention group (n=180), whereas differences in overall EI, stress, and well-being were not significant. Significant differences were found in EI subdomains, self-emotional awareness and emotional expression, and in burnout components, emotional exhaustion and tension. Mediation analysis highlighted the significant role of stress and burnout prevention in the relationship between EI and well-being (p<0.001). These findings suggest that targeted development programs can strengthen EI competencies and improve pharmacists' well-being.

  • Open Access

    Self-assessment of symptoms of depression, anxiety and stress among employees in community pharmacies in Serbia

    by T. Šipetić, N. Bogavac-Stanojević, V. Marinković

    Working in community pharmacies involves high levels of responsibility and constant patient interaction, which can negatively impact mental health of healthcare professionals. Understanding the prevalence of anxiety, depression, and stress is important for the well-being of employees and can potentially impact patient safety culture. The aim of the study was to examine the presence of symptoms of anxiety, depression and stress among employed health professionals in public pharmacies in Serbia based on their self-assessment, and to identify their relationship with demographic and professional characteristics. In a cross-sectional study conducted in May 2026, 836 pharmacists and pharmacy technicians employed in various types of pharmacies participated voluntarily in an anonymous survey. Self-assessment of depression, stress, and anxiety levels was conducted using a standardized and validated DASS-21 questionnaire. Pearson's chi-squared test was used for data analysis. According to the DASS-21 questionnaire, depression was present in 4.5%, anxiety in 5%, and stress in 1.9% of pharmacists. Women were significantly more likely to exhibit symptoms of anxiety compared to men (p=0.015). A significantly higher risk of depression was observed among participants with a higher average number of prescriptions (p=0.029) and "transient" patients (p=0.002). The type of pharmacy (p=0.018) and interactions with different patient groups (p<0.001) were key factors associated with the level of stress. Although the prevalence of stress, anxiety, and depression symptoms is low, factors such as workload and patient structure significantly affect mental well-being. Preventive strategies are necessary to enhance pharmacists' work practices and reduce factors contributing to stress, depression, and anxiety in pharmacy practice.

  • Open Access

    Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend

    by Ivana Stević, Slobodan M. Janković, Marija Mihailović, Ivana Jović, Marina Odalović, Valentina Marinković, Dragana Lakić

    Background/Objectives: Underreporting is very common in drug-induced cytopenias (DICs) due to the late onset of symptoms and the need for laboratory confirmation and monitoring. This research aimed to analyze spontaneously reported adverse drug reaction (ADR) cases of leucopenia, anemia, thrombocytopenia, and total cytopenia, including their reporting structure, rate, and trend, globally (World) and in Serbia. Methods: Based on real-world data from VigiBase, analyses of the DIC reporting structure, rate, and trend over 10 years (2014–2023) were performed. The reporting rate was calculated and expressed as the number of reports per 1,000,000 inhabitants per year (ADR/million/year). Statistics included descriptions, a chi-square test, joinpoint analysis, and measures of variability. Results: Leucopenia was reported more often in Serbia compared to World (1.26 versus 0.96 reports/million/year, respectively), anemia more often in World (2.09 versus 1.75 reports/million/year), while thrombocytopenia reporting was comparable (1.83 reports/million/year globally versus 1.82 reports/million/year in Serbia). In Serbia, there was a constant increase in reporting throughout the observed period, regardless of the cytopenia type, while globally, anemia reports decreased over time. Most of the reported DICs were serious and occurred in females aged 45–64 years. In Serbia, 76.34% of DICs were reported by physicians compared to 31.72% globally. Conclusions: Although upward trends in DIC reporting are observed, variability in reporting between years was greater in Serbia than in World. Many measures are needed to promote the early detection of DICs, with the priority of increasing access to blood count results for all healthcare workers, including pharmacists.

  • Open Access

    Assessing potentially inappropriate medication use among older adults in Central and Eastern Europe

    by Jovana Brkic, Jindra Reissigova, Betul Okuyan, Maja Ortner Hadziabdic, Valentina Marinkovic, Annemie Somers, Graziano Onder, Sofija Sesto, Oznur Altiparmak, Ingrid Kummer, et al.

    The aim of this study was to examine the prevalence of potentially inappropriate medication (PIM) use and its associated risk factors in community-dwelling older adults from five Central and Eastern European (CEE) countries. This secondary analysis of a cross-sectional survey, which was part of the Horizon 2020 EuroAgeism ESR7 project, was conducted between February 2019 and March 2020 in Bulgaria, Croatia, Czechia, Estonia, and Serbia. We enrolled older adults aged ≥65 years who visited community pharmacies to acquire medications. The prevalence of PIM use was determined by applying all 282 criteria from the EU(7)-PIM list. Risk and protective factors for PIM use were evaluated using multiple logistic regression. R software version 4.3.2 was used in statistical analysis. Most of the 2,155 participants were women (63.3%) and aged 65-74 years (64.8%). The overall PIM prevalence was 56.0% (95% confidence interval 53.8%-58.1%), ranging from 29.5% in Czechia to 70.0% in Croatia. The most commonly used PIMs were benzodiazepines (16.7% of all PIMs), followed by nonsteroidal anti-inflammatory drugs (14.3%), and proton pump inhibitors taken for more than 8 weeks (14.1%). Multiple logistic regression revealed that residence, increasing comorbidity burden, and polypharmacy were significant risk factors associated with PIM use in older adults. Our findings demonstrate a high prevalence of PIM use among older patients from CEE countries and considerable cross-country differences, underscoring the need to improve medication prescribing for older adults to improve healthcare quality and patient outcomes.


  • Open Access

    Developing Soft Skills for Sustainable Community Pharmacy Practice Through a Competency-Based Modular Programme

    by Ivana Zimonjić, Lazar Dražeta, Valentina Marinković, Tatjana Milošević

    This study explored a competency-based soft-skills programme supporting evolving community pharmacy professionals’ roles and sustainable practice in Serbia. Four researchers with academic and practice backgrounds developed the programme using healthcare guidelines and the International Pharmaceutical Federation’s competency framework. The process involved defining objectives, selecting methods, designing and organising activities, accreditation, and evaluating outcomes based on the Kirkpatrick model. From January 2021 to March 2025, the “Galenika Academy” was implemented through webinars, accredited tests, onsite courses, and a mobile application. Satisfaction was assessed via a validated online questionnaire among participants attending ≥80% of sessions, following evaluation of attendance and test performance. The programme reached 5107 participants, 10,427 webinar views, and 8252 test completions. The “Galiverse” mobile app, launched in February 2023, had 5558 users by March 2025. The most attended webinar was “Burnout” (787). Average test success was 82.9%, with 95.3% for “Resilience” and 61.0% for “Team Management.” Satisfaction was 95.5% for content, 94.2% for quality, 92.3% for materials, 77.1% for the application, and 96.3% would recommend it. Among those reporting improved resilience, 96.9% believed it could positively impact pharmacy operations. Pharmacists found the programme relevant and effective. Further research is needed to evaluate its impact on practice and patient outcomes.